ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 154 filers reported holding ALLOGENE THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 7.07 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $74,825 | -35.8% | 23,604 | +0.7% | 0.00% | – |
Q2 2023 | $116,517 | +0.6% | 23,444 | 0.0% | 0.00% | – |
Q1 2023 | $115,813 | -21.5% | 23,444 | 0.0% | 0.00% | – |
Q4 2022 | $147,463 | -41.2% | 23,444 | +0.8% | 0.00% | -100.0% |
Q3 2022 | $251,000 | -5.3% | 23,254 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $265,000 | +25.6% | 23,254 | +0.3% | 0.00% | – |
Q1 2022 | $211,000 | -39.0% | 23,184 | 0.0% | 0.00% | -100.0% |
Q4 2021 | $346,000 | -40.7% | 23,184 | +2.2% | 0.00% | 0.0% |
Q3 2021 | $583,000 | -1.5% | 22,684 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $592,000 | -22.3% | 22,684 | +5.0% | 0.00% | -50.0% |
Q1 2021 | $762,000 | +37.8% | 21,597 | -1.4% | 0.00% | +100.0% |
Q4 2020 | $553,000 | -33.1% | 21,897 | 0.0% | 0.00% | -50.0% |
Q3 2020 | $826,000 | +6.4% | 21,897 | +20.8% | 0.00% | 0.0% |
Q2 2020 | $776,000 | +219.3% | 18,127 | +93.8% | 0.00% | +100.0% |
Q4 2019 | $243,000 | +4.7% | 9,355 | +10.1% | 0.00% | 0.0% |
Q3 2019 | $232,000 | +1.8% | 8,495 | 0.0% | 0.00% | 0.0% |
Q2 2019 | $228,000 | – | 8,495 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vida Ventures Advisors, LLC | 1,798,163 | $5,700,177 | 8.82% |
Wildcat Capital Management, LLC | 1,920,787 | $6,088,895 | 2.44% |
TPG GP A, LLC | 18,716,306 | $59,330,690 | 1.02% |
EcoR1 Capital, LLC | 4,488,200 | $14,227,594 | 0.48% |
CROSSPOINT FINANCIAL, LLC | 12,000 | $38,040 | 0.40% |
Coastal Bridge Advisors, LLC | 406,847 | $1,289,705 | 0.35% |
CAXTON ASSOCIATES LP | 480,104 | $1,521,930 | 0.21% |
Woodline Partners LP | 5,313,915 | $16,845,111 | 0.20% |
Rhenman & Partners Asset Management AB | 300,000 | $951,000 | 0.10% |
Navalign, LLC | 75,365 | $238,907 | 0.09% |